OTC · Financial Statements
Immunovia AB (IMMVF) Financial Statements
$0.02
OTC: IMMVF
Market Cap $6.11M
Overview Financials Dividend
Immunovia AB most recently reported annual revenue of $1.0M, a net loss of $146.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $1.0M $1.0M $2.0M $1.0M $1.0M Operating Profit $-167.0M $-191.0M $-296.0M $-109.0M $-80.0M Net Profit $-156.0M $-168.0M $-309.0M $-77.0M $-146.0M EPS $-6.40 $-6.89 $-7.95 $-0.93 $-0.42 Op Margin -19742.7% -16694.3% -18822.9% -11752.0% -11774.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $494.0M $301.0M $99.0M $33.0M $88.0M Total Liabilities $60.0M $57.0M $32.0M $21.0M $23.0M Cash $287.0M $106.0M $77.0M $25.0M $77.0M Borrowings $33.0M $38.0M $4.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-153.0M $-176.0M $-147.0M $-97.0M $-78.0M Investing Cash Flow $-48.0M $-4.0M $2.0M $0 $-6.0M Financing Cash Flow $-6.0M $-6.0M $-6.0M $-8.0M $-1.0M Net Cash Flow $-181.0M $-181.0M $-29.0M $-51.0M $56.0M Free Cash Flow $-177.0M $-177.0M $-148.0M $-97.0M $-78.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -0.08 FCF Yield -130.85% Quick Ratio 3.04 Interest Coverage -2.94 Return 1Y -61.59% Return 3Y -98.17% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .